These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2296255)

  • 1. Induction of chorea and dystonia in parkinsonian primates.
    Boyce S; Clarke CE; Luquin R; Peggs D; Robertson RG; Mitchell IJ; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):3-7. PubMed ID: 2296255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
    Page RD; Sambrook MA; Crossman AR
    Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.
    Papa SM; Chase TN
    Ann Neurol; 1996 May; 39(5):574-8. PubMed ID: 8619541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
    Rupniak NM; Boyce S; Steventon MJ; Iversen SD; Marsden CD
    Ann Neurol; 1992 Jul; 32(1):103-5. PubMed ID: 1642462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Sambrook MA; Mitchell IJ; Crossman AR
    J Neurol Sci; 1987 May; 78(3):273-80. PubMed ID: 3495642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
    Johnston TH; van der Meij A; Brotchie JM; Fox SH
    Mov Disord; 2010 Jul; 25(10):1379-90. PubMed ID: 20310030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK; Jackson M; Smith L; Jenner P; Marsden CD
    Mov Disord; 1995 Nov; 10(6):731-40. PubMed ID: 8749992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
    Mitchell IJ; Luquin R; Boyce S; Clarke CE; Robertson RG; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):49-54. PubMed ID: 2296259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Gomez-Ramirez J; Johnston TH; Visanji NP; Fox SH; Brotchie JM
    Mov Disord; 2006 Jun; 21(6):839-46. PubMed ID: 16532454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys.
    Palfi S; Leventhal L; Goetz CG; Hantraye T; Roitberg BZ; Sramek J; Emborg M; Kordower JH
    Mov Disord; 2000 May; 15(3):524-30. PubMed ID: 10830419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating levodopa-induced dyskinesias in the parkinsonian primate.
    Langston JW; Quik M; Petzinger G; Jakowec M; Di Monte DA
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S79-89. PubMed ID: 10762135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR
    J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
    Bezard E; Hill MP; Crossman AR; Brotchie JM; Michel A; Grimée R; Klitgaard H
    Eur J Pharmacol; 2004 Feb; 485(1-3):159-64. PubMed ID: 14757136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D; Gross C; Lebrun-Grandié P; Bioulac B
    C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
    Iravani MM; Tayarani-Binazir K; Chu WB; Jackson MJ; Jenner P
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1225-34. PubMed ID: 16959959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of thalamotomy in the treatment of levodopa-induced dyskinesia.
    Page RD
    Acta Neurochir (Wien); 1992; 114(3-4):77-117. PubMed ID: 1580197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.